HWHG(SH:600079) Zheng Quan Zhi Xing·2025-09-01 09:20Core Viewpoint - The announcement details a change in the equity stake of the controlling shareholder,招商生命科技（武汉）有限公司, which has increased its shareholding in 人福医药集团股份公司 from 26.30% to 27.14% through market transactions, triggering a 1% threshold change [1][2]. Group 1: Shareholding Changes - The controlling shareholder,招商生命科技（武汉）有限公司, and its concerted parties have increased their total shareholding from 429,276,816 shares to 442,926,074 shares [2]. - The increase in shareholding represents a rise of 0.84 percentage points, moving from 26.30% to 27.14% [1][2]. - This equity change does not violate any prior commitments made by the shareholder [1]. Group 2: Investment Intentions -招商生命科技（武汉）有限公司 had previously announced a plan to increase its shareholding by at least 1% and not exceeding 2% within a six-month period, with a maximum purchase price set at 25.53 yuan per share [1][2]. - The increase in shareholding is based on the controlling shareholder's confidence in the company's future development and long-term investment value [1]. Group 3: Compliance and Reporting - The company confirms that the information provided by the controlling shareholder is accurate and complete, with no misleading statements or significant omissions [1]. - The company will fulfill its information disclosure obligations in accordance with the progress of the shareholding increase [3].